The FDA’s approval for expanded use reinforces LP-310’s potential as a new therapeutic option for OLP and supports ongoing clinical development efforts.

The new indication adds to the 2021 approval of Susvimo (ranibizumab) for 'wet' or neovascular age-related macular ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years ...

Watch skilled mechanics in action as they replace the diesel valve stem seals of a Nissan truck with precision and expertise.

The U.S. Food and Drug Administration (FDA) has approved the labeling of Chilean salmon as “healthy” – a move which ...

Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...

Instylla, Inc., a developer of solutions for peripheral vascular embolotherapy, announced the FDA 510(k) clearance of the ...

That’s because there is an inverse relationship between presidential approval ratings and the stock market, according to an analysis conducted by Ned Davis Research. Donald Trump’s approval ...

The FDA also gave its nod to Bristol Myers Squibb’s Cobenfy (xanomeline and trospium chloride), the first new class of antischizophrenia drug to be approved in decades. Roughly one-third of last ...